We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
Turnover
16.03%
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Avg Time Held
5.4
years
Top 10 Avg Time Held
1.7
years
Top 20 Avg Time Held
2.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1126
ASE Group
ASX
$109B
| $1.08M | ﹤0.01% |
104,136
| – | – |
2021 Q2
16 quarters
|
|
1127
Medifast
MED
$135M
| $1.08M | ﹤0.01% |
76,549
-99,221
| -56% | -$1.3M |
2013 Q2
48 quarters
|
|
1128
American Homes 4 Rent
AMH
$11.1B
| $1.07M | ﹤0.01% |
29,728
-373
| -1% | -$13.8K |
2020 Q2
20 quarters
|
|
1129
Annaly Capital Management
NLY
$13.9B
| $1.06M | ﹤0.01% |
56,486
+7,748
| +16% | +$147K |
2021 Q2
16 quarters
|
|
1130
Toll Brothers
TOL
$12.3B
| $1.06M | ﹤0.01% |
9,283
-176
| -2% | -$18.3K |
2013 Q2
48 quarters
|
|
1131
Visteon
VC
$2.37B
| $1.06M | ﹤0.01% |
11,352
-21,303
| -65% | -$1.75M |
2018 Q2
28 quarters
|
|
1132
Vicor
VICR
$10.1B
| $1.06M | ﹤0.01% |
23,329
-91,936
| -80% | -$4.11M |
2024 Q2
4 quarters
|
|
1133
Criteo S.A.
CRTO
$772M
| $1.06M | ﹤0.01% |
44,059
-46,362
| -51% | -$1.31M |
2023 Q1
9 quarters
|
|
1134
Dolby
DLB
$5.7B
| $1.05M | ﹤0.01% |
14,133
-11,962
| -46% | -$895K |
2018 Q3
27 quarters
|
|
1135
Vestis
VSTS
$1.9B
| $1.05M | ﹤0.01% |
183,038
+61,449
| +51% | +$431K |
2023 Q4
6 quarters
|
|
1136
Stride
LRN
$3.46B
| $1.05M | ﹤0.01% |
7,218
-76
| -1% | -$11K |
2023 Q3
7 quarters
|
|
1137
Biomea Fusion
BMEA
$60.6M
| $1.04M | ﹤0.01% |
576,364
-17,757
| -3% | -$34.2K |
2024 Q4
2 quarters
|
|
1138
Aramark
ARMK
$14.5B
| $1.02M | ﹤0.01% |
24,465
-638
| -3% | -$23.7K |
2023 Q1
9 quarters
|
|
1139
EnerSys
ENS
$6.23B
| $1.02M | ﹤0.01% |
11,935
-21,860
| -65% | -$1.91M |
2013 Q2
48 quarters
|
|
1140
Carlyle Group
CG
$13.1B
| $1.02M | ﹤0.01% |
19,891
-92
| -0.5% | -$3.96K |
2023 Q4
6 quarters
|
|
1141
Rackspace Technology
RXT
$813M
| $1.02M | ﹤0.01% |
795,067
+609
| +0.1% | +$793 |
2022 Q4
10 quarters
|
|
1142
DELISTED
AvalonBay Communities
AVB
| $1.01M | ﹤0.01% |
4,961
-1,376
| -22% | -$281K |
2013 Q2
48 quarters
|
|
1143
Occidental Petroleum
OXY
$60.6B
| $1.01M | ﹤0.01% |
23,997
+20,985
| +697% | +$877K |
2013 Q2
48 quarters
|
|
1144
Ally Financial
ALLY
$11.5B
| $1.01M | ﹤0.01% |
25,853
-2,105
| -8% | -$72.9K |
2014 Q3
43 quarters
|
|
1145
Alerus Financial
ALRS
$766M
| $1.01M | ﹤0.01% |
46,461
-536
| -1% | -$10.7K |
2024 Q1
5 quarters
|
|
1146
Chewy
CHWY
$8.57B
| $1.01M | ﹤0.01% |
23,589
+7,904
| +50% | +$315K |
2024 Q4
2 quarters
|
|
1147
Alliant Energy
LNT
$17.4B
| $989K | ﹤0.01% |
16,350
-11,326
| -41% | -$693K |
2018 Q3
27 quarters
|
|
1148
HealthEquity
HQY
$7.65B
| $983K | ﹤0.01% |
9,383
-373
| -4% | -$35.4K |
2017 Q3
31 quarters
|
|
1149
Cal-Maine
CALM
$2.97B
| $958K | ﹤0.01% |
9,615
+9,594
| +45,686% | +$917K |
2022 Q2
12 quarters
|
|
1150
MACOM Technology Solutions
MTSI
$20.7B
| $957K | ﹤0.01% |
6,676
-163
| -2% | -$19K |
2019 Q4
22 quarters
|
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.